所有图片(1)
About This Item
经验公式（希尔记法）:
C15H11FN2
CAS号:
分子量:
238.26
MDL编号:
UNSPSC代码:
12352200
PubChem化学物质编号:
NACRES:
NA.77
质量水平
检测方案
≥98% (HPLC)
形式
powder
颜色
white to beige
溶解性
DMSO: ≥10 mg/mL
储存温度
2-8°C
SMILES字符串
Fc1ccc2c(\C=C\c3cccnc3)c[nH]c2c1
InChI
1S/C15H11FN2/c16-13-5-6-14-12(10-18-15(14)8-13)4-3-11-2-1-7-17-9-11/h1-10,18H/b4-3+
InChI key
YBSDQTBCNYWBMX-ONEGZZNKSA-N
应用
680C91可用于：
- 作为色氨酸 2,3 双加氧酶（TDO）抑制剂，研究其对长鳍近海鱿鱼胚胎色素沉积的影响
- 作为 TDO 抑制剂，研究其在异种移植瘤实验中对食管鳞状细胞癌的影响
- 作为色氨酸 2,3 双加氧酶 2 （TDO2）抑制剂，研究其对人胚胎肾细胞毒性片段形成的影响
生化/生理作用
680C91 对单胺氧化酶 A 和 B、吲哚胺 2,3-双加氧酶和 5-羟色胺（5-HT）摄取以及 5-HT1A、1D、2A 和 2C 受体无抑制作用。
680C91 是色氨酸 2,3-双加氧酶（TDO）的有效抑制剂，该酶可指导色氨酸转化为犬尿氨酸。最近，犬尿氨酸被鉴定为芳烃受体（AHR）的内源性配体。TDO 在神经胶质瘤细胞中高表达，并有助于 AHR 介导的神经胶质瘤细胞存活并抑制抗肿瘤免疫反应。
警示用语：
Danger
危险声明
危险分类
Eye Dam. 1
WGK
WGK 3
闪点(°F)
Not applicable
闪点(°C)
Not applicable
Carlo Breda et al.
Proceedings of the National Academy of Sciences of the United States of America, 113(19), 5435-5440 (2016-04-27)
Metabolites of the kynurenine pathway (KP) of tryptophan (TRP) degradation have been closely linked to the pathogenesis of several neurodegenerative disorders. Recent work has highlighted the therapeutic potential of inhibiting two critical regulatory enzymes in this pathway-kynurenine-3-monooxygenase (KMO) and tryptophan-2,3-dioxygenase
Tryptophan 2, 3-dioxygenase 2 controls M2 macrophages polarization to promote esophageal squamous cell carcinoma progression via AKT/GSK3 beta IL-8 signaling pathway
Zhao Y, et al.
Acta pharmaceutica Sinica. B (2021)
Karthyayani Rajamani et al.
Neuropharmacology, 117, 434-446 (2017-02-23)
Spinocerebellar ataxia type 3 or Machado-Joseph disease (SCA3/MJD) is characterized by the repetition of a CAG codon in the ataxin-3 gene (ATXN3), which leads to the formation of an elongated mutant ATXN3 protein that can neither be denatured nor undergo
Different effects of tryptophan 2,3-dioxygenase inhibition on SK-Mel-28 and HCT-8 cancer cell lines.
Sara Paccosi et al.
Journal of cancer research and clinical oncology, 146(12), 3155-3163 (2020-08-11)
Indoleamine 2,3-dioxygenase-1 (IDO1) and more recently, tryptophan 2,3-dioxygenase (TDO), are tryptophan-catabolizing enzymes with immunoregulatory properties in cancer. IDO1 is more expressed than TDO in many tumours including melanomas; however, IDO inhibitors did not give expected results in clinical trials, highlighting
Lisa I Greene et al.
Molecular cancer research : MCR, 17(1), 131-139 (2018-08-26)
Tryptophan catabolism is an attractive target for reducing tumor progression and improving antitumor immunity in multiple cancers. Tumor infiltration by CD8 T cells correlates with improved prognosis in triple-negative breast cancer (TNBC) and a significant effort is underway to improve
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门